XenoPort, Inc. (NASDAQ:XNPT)
CAPS Rating:
A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.
RSS Headlines
Fool UK
Recs
FDA
Terrible fundamentals and an unpredictable business. Don't waste you money with this.